Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma
Open Access
- 18 November 2004
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 77 (4) , 351-357
- https://doi.org/10.1002/ajh.20215
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- MTHFR 677C→T Polymorphism and Risk of Coronary Heart DiseaseJAMA, 2002
- Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphomaBlood, 2001
- Normal Frequencies of the C677T Genotypes on the Methylenetetrahydrofolate Reductase (MTHFR) Gene Among Lymphoproliferative Disorders but not in Multiple MyelomaLeukemia & Lymphoma, 2000
- Regulated Genomic Instability and Neoplasia in the Lymphoid LineageBlood, 1999
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999
- Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adultsProceedings of the National Academy of Sciences, 1999
- A Second Common Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects?American Journal of Human Genetics, 1998
- Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesisCarcinogenesis: Integrative Cancer Research, 1997
- Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disordersHuman Molecular Genetics, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995